Advancing IBD Practice in Our Communities: A Focus on Evidence-based Care

Advancing IBD Practice in Our Communities: A Focus on Evidence-based Care

On-Demand Webcast

Provided by the North American Center for Continuing Medical Education and the American Gastroenterological Association 

Faculty

Raymond Cross, MD, MS, AGAF
Associate Professor of Medicine 
Division of Gastroenterology and Hepatology
Director of the Inflammatory Bowel Disease Program
University of Maryland School of Medicine
Co-Director Digestive Health Center
University of Maryland Medical Center
Baltimore, Maryland

Millie D. Long, MD, MPH
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Intended Learners

This activity is designed for gastroenterological specialists, physicians, nurse practitioners, physician assistants, nurses, and other allied healthcare professionals

Learning Objectives

After participating in this activity, participants should be able to:

  • Implement guideline and evidence--‐based strategies to optimize the assessment of IBD, as well as the prevention and monitoring of associated complications and comorbidities
  • Describe currently approved biologic treatments for IBD, as well as their inflammatory pathway targets and placement within the IBD treat--‐to--‐target algorithm
  • Translate clinical evidence of biological therapeutic approaches into the early and effective management of IBD
  • Adopt shared decision--‐making strategies that include comprehensive patient engagement tools focused on improving self--‐management, adherence, and outcomes
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10 question post-test with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring webcast.

Release Date: December 30, 2016
Expiration Date: December 30, 2017
Estimated time to complete: 1.25 hours

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs (please download here). A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation
CME

The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The AGA Institute designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

CNE

  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This continuing nursing education activity awards 1.25 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.25 contact hour.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

Planning Committee

The planning committee comprises Raymond Cross, MD, MS, AGAF, Millie D. Long, MD, MPH, Bret Lashner, MD; Susie Seaman, NP; Maura H. Davis and Sandra Megally, AGA; and Donna Brophy, Celeste Collazo, MD, Mary Johnson, Michael Kearney, Randy Robbin, and John Savage and Margaret Stefan, NACCME.

Independent Clinical Reviewer: Bret Lashner, MD, Professor of Medicine, Cleveland Clinic, Cleveland, Ohio

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Dr. Cross: Consultant—Abbvie, UCB; Grant/Research Support—Abbvie, Janssen, Shire, Takeda; Advisory Board—Abbvie, Janssen

Dr. Long: Consultant—Abbvie, Pfizer, Takeda, Theravance

Ms. Seaman: Scientific Advisor—Smith & Nephew; Promotional Speakers’ Bureau—Smith & Nephew

Dr. Lashner disclosed no relevant financial relationships with any commercial interest.

Ms. Brophy, Dr. Collazo,  Ms. Davis, Ms. Johnson, Mr. Kearney, Ms. Megally, Mr. Robbin, Mr. Savage,and Ms. Stefan have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed no off label/unapproved uses of drugs and/or devices will be discussed in the presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2016 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.